Literature DB >> 10798134

Pediatric gastritis and peptic ulcer disease.

U Blecker1, D I Mehta, B D Gold.   

Abstract

Inflammation of the gastric and duodenal mucosa is the end result of an imbalance between mucosal defensive and aggressive factors. The degree of inflammation and imbalance between defensive and aggressive factors can then result in varying degrees of gastritis and/or mucosal ulceration. Gastritis and ulcers of the duodenum or stomach can be classified as primary or secondary. The majority of children with chronic gastritis and ulcers in the stomach or duodenum have secondary inflammation or mucosal ulceration. These secondary ulcers generally occur due to a systemic condition like head trauma or overwhelming sepsis, or as sequelae to drug ingestion (i.e. non-steroidal anti-inflammatory agents), but secondary gastroduodenal ulcers can also occur in specific disease conditions such as Zollinger-Ellison syndrome or Crohn's disease. In almost all children with primary duodenal or gastric ulcers mucosal inflammation and, less frequently, ulceration is caused by a spiral shaped, gram-negative, microaerobic rod Helicobacter pylori. Recent epidemiological evidence has linked chronic H. pylori infection with the development of gastric carcinomas.

Entities:  

Mesh:

Year:  1999        PMID: 10798134     DOI: 10.1007/bf02726263

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  23 in total

Review 1.  Current management of patients with stress ulceration.

Authors:  G O'Keefe; R V Maier
Journal:  Adv Surg       Date:  1996

2.  Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs.

Authors:  W E Smalley; M R Griffin; R L Fought; W A Ray
Journal:  J Gen Intern Med       Date:  1996-08       Impact factor: 5.128

3.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

4.  Serum pepsinogen I and gastrin concentrations in children positive for Helicobacter pylori.

Authors:  G Oderda; D Vaira; D Dell'Olio; J Holton; M Forni; F Altare; N Ansaldi
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

Review 5.  Gastrointestinal effects of NSAIDs. Difficulties in detection and management.

Authors:  S P Pearson; I Kelberman
Journal:  Postgrad Med       Date:  1996-11       Impact factor: 3.840

6.  Changes in the structure of the mucous gel on the mucosal surface of the stomach in association with peptic ulcer disease.

Authors:  F Younan; J Pearson; A Allen; C Venables
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

7.  Autoantibodies cytotoxic to gastric parietal cells in serum of patients with pernicious anemia.

Authors:  H J De Aizpurua; L J Cosgrove; B Ungar; B H Toh
Journal:  N Engl J Med       Date:  1983-09-15       Impact factor: 91.245

8.  Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer.

Authors:  J I Isenberg; J A Selling; D L Hogan; M A Koss
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

9.  Experience with misoprostol therapy for NSAID gastropathy in children.

Authors:  M Gazarian; M Berkovitch; G Koren; E D Silverman; R M Laxer
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

10.  Helicobacter pylori infection in children: clinical, endoscopic, and histologic correlations.

Authors:  G Prieto; I Polanco; J Larrauri; L Rota; R Lama; S Carrasco
Journal:  J Pediatr Gastroenterol Nutr       Date:  1992-05       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.